Photo by cdc from unsplash
Multiple sclerosis (MS) is a chronic disease of the central nervous system that disproportionately affects women, with typical onset during reproductive age. Several disease‐modifying therapies (DMTs) are FDA‐approved to slow… Click to show full abstract
Multiple sclerosis (MS) is a chronic disease of the central nervous system that disproportionately affects women, with typical onset during reproductive age. Several disease‐modifying therapies (DMTs) are FDA‐approved to slow disease progression, but are not indicated for use during pregnancy. Our objective was to describe trends over time (2010–2019) in monthly point prevalence of DMT use among reproductive‐age women, overall and by generic name.
Keywords:
modifying therapies;
2010 2019;
disease modifying;
multiple sclerosis;
among reproductive
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pharmacoepidemiology and Drug Safety
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!